Taoqian Zhao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Development of Novel 18 F-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography”.

Development of Novel 18 F-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00474

N/A

0DataRank · unranked

1 citations

Chunyu Zhao, Ahmad Chaudhary, Jiahui Chen, Yinlong Li, Xin Zhou +12 more

Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetry

American Journal of Nuclear Medicine and Molecular Imaging(2025)10.62347/kjlm2547

N/A

0DataRank · unranked

1 citations

Taoqian Zhao

The Promise of Selective PARP1 Inhibitors in Cancer Therapy

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00561

N/A

0DataRank · unranked

1 citations

Jimmy S. Patel, Taoqian Zhao, Steven H. Liang, Xin Zhou

PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00160

N/A

0DataRank · unranked

0 citations

Steven H. Liang, Taoqian Zhao

Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementias

American Journal of Nuclear Medicine and Molecular Imaging(2025)10.62347/ergq2963

N/A

0DataRank · unranked

0 citations

Taoqian Zhao